CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 40 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $118 | -92.4% | 271 | -88.6% | 0.00% | – |
| Q4 2022 | $1,553 | – | 2,367 | +557.5% | 0.00% | – |
| Q3 2022 | $0 | – | 360 | -10.0% | 0.00% | – |
| Q2 2022 | $0 | – | 400 | +6.4% | 0.00% | – |
| Q1 2022 | $0 | – | 376 | +0.5% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 374 | -1.6% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 380 | +20.6% | 0.00% | – |
| Q2 2021 | $1,000 | -95.2% | 315 | -96.0% | 0.00% | – |
| Q1 2021 | $21,000 | -86.4% | 7,808 | -84.5% | 0.00% | – |
| Q4 2020 | $154,000 | -11.0% | 50,522 | +77.9% | 0.00% | – |
| Q3 2020 | $173,000 | -15.6% | 28,392 | -18.1% | 0.00% | – |
| Q2 2020 | $205,000 | +41.4% | 34,673 | -36.8% | 0.00% | – |
| Q1 2020 | $145,000 | +22.9% | 54,903 | +26.2% | 0.00% | – |
| Q4 2019 | $118,000 | -83.7% | 43,520 | -26.9% | 0.00% | – |
| Q3 2019 | $722,000 | +77.0% | 59,496 | +67.3% | 0.00% | – |
| Q2 2019 | $408,000 | – | 35,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |